• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Potential gene target identified for colorectal cancer treatment [PreClinical]

byCorinne FoleyandJessica Lau
June 18, 2016
in Oncology, Preclinical
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

 

1. Blocking Tacc3, a gene involved in mitotic spindle assembly, decreased the proliferation of intestinal stem cells in a 3D cell culture system.

2. When Tacc3 was blocked in a mouse model of colorectal cancer, a decrease in tumor growth and increase in survival were observed.

Evidence Rating Level: 2 (Good)

Study Rundown: One of the most common genetic mutations found in human colorectal cancer is an inactivating mutation in the adenomatous polyposis coli (Apc) protein, leading to an increase in expression and renewal of intestinal stem cells. Following Apc inactivation, the gene TOGp is constitutively overexpressed in colorectal cancers. Because TOGp is known to interact with Tacc3, the potential therapeutic efficacy of inhibiting Tacc3 was assessed in this study.

First, organoid 3D cell cultures were used to evaluate the effect of Apc and Tacc3 inactivation on intestinal stem cell expression. When Apc was inactivated, there was a significant increase in the expression of stem cell markers. In addition, the crypt-like domains, areas in the intestine that naturally contain stem cells, were found to be expanded. Tacc3 was also located in these crypt-like domains, and deletion of this gene prevented the increase in stem cell expression and crypt domain expansion. Next, Apc-deficient mice were used as a model for colorectal cancer. Compared to mice that expressed Tacc3, the Tacc3 knockout mice had both a significantly increased survival rate as well as a decrease in tumor load.

RELATED REPORTS

Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use

Artificial intelligence based clinical decision systems are safe and effective for diabetes management

Epic Launchpad propels generative-AI into everyday hospital routines

The researchers in this study were able to not only decrease tumor growth in vitro and in vivo¸ but they also showed increased survival in mice. Although these experiments were preliminary, they have potential implications in treating colorectal cancer by directly targeting the Tacc3 gene. Further studies will need to assess the potential of a targeted therapeutic agent to inhibit this pathway and determine its efficacy in reducing tumor load.

Click to read the study in Oncogene

Relevant Reading: TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma

In-Depth [animal study]: Both in vitro intestinal organoids and a mouse model were used to assess the location and function of Tacc3 in the context of Apc-inactivated colorectal cancer. In the intestinal organoid system, 4-hydroxytamoxifen treatment was used to inactivate Apc. Microarray and confirmatory qPCR analyses showed an increase in the expression of a variety of intestinal stem cell markers (p< 0.05). Immunofluorescence was then used to visualize the location of these stem cells, and their typical location, crypt-like domains, was found to be expanded. Upon Tacc3 inactivation, the increase in stem cell marker expression was prevented (p< 0.05), and crypt-like domains were not expanded.

Next, Apc-deficient mice were genetically engineered to have either Tacc3 conditional expression or complete Tacc3 disruption. Tumor growth and survival were evaluated, and there was a significant increase in survival (p< 0.0001) and a significant decrease in tumor load (p< 0.05) for the Tacc3 complete knockout animals.

Finally, the specific subset of stem cells affected by Tacc3 disruption was analyzed using immunofluorescence. Adenomas from mice that did not express Tacc3 were found to have decreased expression of Lgr5, one of the stem cell expression markers. In contrast, another stem cell marker, EphB2, was still expressed.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Opioids for chronic non-cancer pain linked to increased mortality

Next Post

Hypertensive urgency outcomes similar between outpatient management and hospital referral

RelatedReports

American Academy of Pediatrics recommends standards for adverse event disclosures
Chronic Disease

Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use

July 3, 2025
Pediatric DKA associated with recent acute care visits
Chronic Disease

Artificial intelligence based clinical decision systems are safe and effective for diabetes management

July 3, 2025
FDA-regulated clinical trials rarely report violations
AI Roundup

Epic Launchpad propels generative-AI into everyday hospital routines

July 3, 2025
#VisualAbstract: Routine Cerebral Embolic Protection Did Not Reduce Stroke Incidence during Transcatheter Aortic-Valve Implantation
All Specialties

#VisualAbstract: Routine Cerebral Embolic Protection Did Not Reduce Stroke Incidence during Transcatheter Aortic-Valve Implantation

July 3, 2025
Next Post
UTI associated with increased risk of preeclampsia

Hypertensive urgency outcomes similar between outpatient management and hospital referral

USPSTF finds insufficient evidence for screening for iron deficiency anemia during pregnancy

Hirschsprung disease associated with maternal obesity and preterm birth

FDA-approved weight loss medications associated with weight loss at one year

FDA-approved weight loss medications associated with weight loss at one year

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.